查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1620668

亚磷酰胺市场：按类型、纯度等级、最终用户、应用分类 - 全球预测 2025-2030

Phosphoramidite Market by Type (DNA Phosphoramidites, Dye-Labeled Phosphoramidites, RNA Phosphoramidites), Purity Level (High Purity, Standard Purity), End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年亚磷酰胺市值为12亿美元，预计2024年将达12.8亿美元，复合年增长率为7.29%，预计到2030年将达到19.7亿美元。

亚磷酰胺是寡核苷酸合成中使用的主要试剂。寡核苷酸是短核酸链，对于基因检测、治疗和研究等多种应用至关重要。它的需求源于它在促进 DNA 和 RNA 化学合成方面的作用，这对于生物製药和基因疗法的开发至关重要。最终用途包括製药公司、生技公司和学术研究机构。市场洞察表明，对个人化医疗的需求不断增长以及基因组和分子诊断应用的不断扩大是关键的成长动力。此外，合成生物学研究投资的增加以及 CRISPR 等基因编辑技术的进步正在创造重大商机。为了利用这些发展，公司可以专注于提高亚磷酰胺的产品纯度、保质期和成本效益。

主要市场统计
基准年[2023] 12亿美元
预测年份 [2024] 12.8亿美元
预测年份 [2030] 19.7亿美元
复合年增长率（%） 7.29%

然而，市场面临挑战，主要是与亚磷酰胺合成相关的高成本以及需要严格的储存条件来维持反应性。监管障碍和品管问题也对市场扩张构成挑战。此外，核酸疗法发展迅速，需要不断创新并需要在研发方面进行大量投资。需要创新的领域包括开发环保合成方法和自动化製造工艺，以提高可扩展性并降低成本。探索生产更有效和稳定的亚磷酰胺类似物的合成路线也将是有益的。

对于寻求发展的公司来说，对合成过程和监管环境的技术理解是关键。与研究机构和生物技术公司建立合作以加速寡核苷酸疗法的进步可以提供竞争优势。以快速技术转变和应用演进为特征的动态市场特征强调了敏捷性和适应性的重要性。认识到这些因素并对技术进步进行策略性投资可以帮助公司在现有市场限制和挑战的情况下成功抓住新机会。

市场动态：揭示快速发展的亚磷酰胺市场的关键市场洞察

供需的动态交互作用正在改变亚磷酰胺市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 研究和治疗应用对 DNA 和 RNA 寡核苷酸的需求不断增加
    • 使用寡核苷酸合成的个人化医疗解决方案的需求快速增长
    • 製药和生物技术产业的扩张
  • 市场限制因素
    • 亚磷酰胺合成中的高成本和扩充性问题
  • 市场机会
    • 政府对生物技术研究的资助激增
    • 生物技术和製药公司之间的持续合作和伙伴关係
  • 市场挑战
    • 与亚磷酰胺合成相关的环境与安全问题

波特五力：驾驭亚磷酰胺市场的策略工具

波特的五力框架是了解亚磷酰胺市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解对亚磷酰胺市场的外部影响

外部宏观环境因素在塑造亚磷酰胺市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解亚磷酰胺市场的竞争格局

对亚磷酰胺市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵亚磷酰胺市场供应商绩效评估

FPNV定位矩阵是评估亚磷酰胺市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了亚磷酰胺市场的成功之路

亚磷酰胺市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 研究和治疗应用对 DNA 和 RNA 寡核苷酸的需求增加
      • 使用寡核苷酸合成的个人化医疗解决方案的需求迅速增长
      • 製药和生物技术产业的扩张
    • 抑制因素
      • 亚磷酰胺合成的高成本和可扩展性问题
    • 机会
      • 政府对生物技术研究的资助激增
      • 生物技术和製药公司之间的持续合作和伙伴关係
    • 任务
      • 与亚磷酰胺合成相关的环境与安全问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章亚磷酰胺市场：依类型

  • DNA亚磷酰胺
  • 染料标记的亚磷酰胺
  • RNA亚磷酰胺
  • 特殊亚磷酰胺

第七章依纯度等级分類的亚磷酰胺市场

  • 高纯度
  • 标准纯度

第八章亚磷酰胺市场：依最终用户分类

  • 学术/研究机构
  • 合约调查机构
  • 诊断实验室
  • 製药/生物技术

第九章亚磷酰胺市场：依应用分类

  • 诊断开发
  • 药物发现与开发

第10章美洲亚磷酰胺市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区亚磷酰胺市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲亚磷酰胺市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Codexis 彻底改变了酶促 RNA 合成技术，提高了效率和扩充性
    • Innovassynth 和 Actylis 合作解决核酸供应链中的漏洞
  • 战略分析和建议
    • 赛默飞世尔科技有限公司

公司名单

  • AAT Bioquest, Inc.
  • Actylis
  • Amadis Chemical Company Limited
  • American International Chemical, LLC by LeBaronBrown Industries LLC
  • Beijing SBS Genetech Co., Ltd.
  • Bioneer Corporation
  • Biosynth Ltd.
  • BOCSCI Inc.
  • ChemGenes Corporation
  • Creative Biolabs, Inc.
  • Hongene Biotech Corporation
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • LGC Genomics Limited
  • Lumiprobe Corporation
  • Maravai LifeSciences Holdings, Inc.,
  • MedChemExpress
  • Merck KGaA
  • PolyOrg, Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Twist Bioscience Corporation
  • Wuhu Huaren Science and Technology Co., Ltd.
Product Code: MRR-EA74537D7BA2

The Phosphoramidite Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 7.29%, to USD 1.97 billion by 2030.

Phosphoramidites are key reagents used in the synthesis of oligonucleotides, which are short strands of nucleic acids vital for various applications, including genetic testing, therapeutics, and research. Necessity arises from their role in facilitating the chemical synthesis of DNA and RNA, critical for the development of biopharmaceuticals and gene therapies. The end-use scope predominantly includes pharmaceuticals, biotechnology companies, and academic research institutions. Market insights reveal that the growing demand for personalized medicine and expanding applications in genomics and molecular diagnostics are the primary growth drivers. Furthermore, the increasing investment in synthetic biology research and technological advancements in gene editing technologies, such as CRISPR, present substantial opportunities. To leverage these developments, companies can focus on enhancing product purity, shelf-life, and cost-effectiveness of phosphoramidites.

KEY MARKET STATISTICS
Base Year [2023] USD 1.20 billion
Estimated Year [2024] USD 1.28 billion
Forecast Year [2030] USD 1.97 billion
CAGR (%) 7.29%

The market, however, faces challenges, primarily the high cost associated with phosphoramidite synthesis and the need for stringent storage conditions to maintain their reactivity. Regulatory hurdles and quality control issues also pose difficulties for market expansion. Moreover, the rapidly evolving nature of nucleic acid therapeutics demands continuous innovation, requiring significant investment in R&D. Areas ripe for innovation include the development of environmentally friendly synthesis methods and automated manufacturing processes to increase scalability and reduce costs. Exploring synthetic routes for producing more efficient and stable phosphoramidite analogs could also be beneficial.

For businesses aiming for growth, understanding the technicalities of the synthesis process and regulatory landscape is key. Establishing collaborations with research institutions and biotech firms to foster advancements in oligonucleotide therapeutics can offer competitive advantages. The dynamic market nature, characterized by rapid technological shifts and evolving application landscapes, underscores the importance of agility and adaptation. Recognizing these factors and strategically investing in technological advancements could position firms to successfully capitalize on emerging opportunities, despite existing market limitations and challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Phosphoramidite Market

The Phosphoramidite Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for DNA and RNA oligonucleotides in research and therapeutic applications
    • Surging demand for personalized medicine solutions utilizing oligonucleotide synthesis
    • Expansion of the pharmaceutical and biotechnology industries
  • Market Restraints
    • High cost and scalability issues with phosphoramidite synthesis
  • Market Opportunities
    • Surge in government funding in biotechnology research
    • Ongoing collaborations and partnerships within biotech and pharmaceutical companies
  • Market Challenges
    • Environmental and safety concerns associated with phosphoramidite synthesis

Porter's Five Forces: A Strategic Tool for Navigating the Phosphoramidite Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Phosphoramidite Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Phosphoramidite Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Phosphoramidite Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Phosphoramidite Market

A detailed market share analysis in the Phosphoramidite Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Phosphoramidite Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Phosphoramidite Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Phosphoramidite Market

A strategic analysis of the Phosphoramidite Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Phosphoramidite Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Actylis, Amadis Chemical Company Limited, American International Chemical, LLC by LeBaronBrown Industries LLC, Beijing SBS Genetech Co., Ltd., Bioneer Corporation, Biosynth Ltd., BOCSCI Inc., ChemGenes Corporation, Creative Biolabs, Inc., Hongene Biotech Corporation, Integrated DNA Technologies, Inc. by Danaher Corporation, LGC Genomics Limited, Lumiprobe Corporation, Maravai LifeSciences Holdings, Inc.,, MedChemExpress, Merck KGaA, PolyOrg, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co., Ltd., Twist Bioscience Corporation, and Wuhu Huaren Science and Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Phosphoramidite Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across DNA Phosphoramidites, Dye-Labeled Phosphoramidites, RNA Phosphoramidites, and Speciality Phosphoramidites.
  • Based on Purity Level, market is studied across High Purity and Standard Purity.
  • Based on End-User, market is studied across Academic & Research Institutions, Contract Research Organizations, Diagnostic Laboratories, and Pharmaceutical & Biotechnology.
  • Based on Application, market is studied across Diagnostics Development and Drug Discovery & Development.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for DNA and RNA oligonucleotides in research and therapeutic applications
      • 5.1.1.2. Surging demand for personalized medicine solutions utilizing oligonucleotide synthesis
      • 5.1.1.3. Expansion of the pharmaceutical and biotechnology industries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and scalability issues with phosphoramidite synthesis
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in government funding in biotechnology research
      • 5.1.3.2. Ongoing collaborations and partnerships within biotech and pharmaceutical companies
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental and safety concerns associated with phosphoramidite synthesis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Phosphoramidite Market, by Type

  • 6.1. Introduction
  • 6.2. DNA Phosphoramidites
  • 6.3. Dye-Labeled Phosphoramidites
  • 6.4. RNA Phosphoramidites
  • 6.5. Speciality Phosphoramidites

7. Phosphoramidite Market, by Purity Level

  • 7.1. Introduction
  • 7.2. High Purity
  • 7.3. Standard Purity

8. Phosphoramidite Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Contract Research Organizations
  • 8.4. Diagnostic Laboratories
  • 8.5. Pharmaceutical & Biotechnology

9. Phosphoramidite Market, by Application

  • 9.1. Introduction
  • 9.2. Diagnostics Development
  • 9.3. Drug Discovery & Development

10. Americas Phosphoramidite Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Phosphoramidite Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Phosphoramidite Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Codexis innovates with enzymatic RNA synthesis to enhance efficiency and scalability
    • 13.3.2. Innovassynth and Actylis partner to address Nucleic Acid supply chain vulnerabilities
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Thermo Fisher Scientific Inc.

Companies Mentioned

  • 1. AAT Bioquest, Inc.
  • 2. Actylis
  • 3. Amadis Chemical Company Limited
  • 4. American International Chemical, LLC by LeBaronBrown Industries LLC
  • 5. Beijing SBS Genetech Co., Ltd.
  • 6. Bioneer Corporation
  • 7. Biosynth Ltd.
  • 8. BOCSCI Inc.
  • 9. ChemGenes Corporation
  • 10. Creative Biolabs, Inc.
  • 11. Hongene Biotech Corporation
  • 12. Integrated DNA Technologies, Inc. by Danaher Corporation
  • 13. LGC Genomics Limited
  • 14. Lumiprobe Corporation
  • 15. Maravai LifeSciences Holdings, Inc.,
  • 16. MedChemExpress
  • 17. Merck KGaA
  • 18. PolyOrg, Inc.
  • 19. QIAGEN N.V.
  • 20. Thermo Fisher Scientific Inc.
  • 21. Tokyo Chemical Industry Co., Ltd.
  • 22. Twist Bioscience Corporation
  • 23. Wuhu Huaren Science and Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PHOSPHORAMIDITE MARKET RESEARCH PROCESS
  • FIGURE 2. PHOSPHORAMIDITE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHOSPHORAMIDITE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHOSPHORAMIDITE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DYE-LABELED PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY RNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY SPECIALITY PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY HIGH PURITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY STANDARD PURITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DIAGNOSTICS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023